Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MyDrHank vs Tyde Wellness

By GLP-1 ScorecardUpdated

MyDrHank
Site position #106

Lower grade

Tyde Wellness
Site position #40

Higher grade

Score comparison

Tyde Wellness has the higher recorded score — 79.8/100 to 68.2/100.

Tyde Wellness grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Tyde Wellness is a 50-state compounded-GLP-1 and longevity telehealth platform spanning weight loss, HRT, hair, and peptides.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueTyde Wellness +16
70
86
Dose & formulationMyDrHank +1
84
83
Clinical oversightTyde Wellness +23
66
89
Labs & monitoringTyde Wellness +4
50
54
FulfillmentTyde Wellness +13
78
91
Contract termsTyde Wellness +13
48
61
MyDrHank · top barTyde Wellness · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricMyDrHankTyde Wellness
WeighScore68.2/10079.8/100
GradeCC+
Site position#106#40
SemaglutideFrom $171/mo oral or injectable on GLP-1 lander; injection product page from $178/mo (conflicting offer terms; confirm)$149/mo (microdose tier, all doses, compounded)
TirzepatideFrom $200/mo on GLP-1 lander; product page from $240/mo (conflicting offer terms; confirm)$249/mo (microdose tier, all doses, compounded)
CoverageConfirm prescription and state; contiguous-U.S. shipping claim does not establish individual eligibilityAll 50 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualYesYes
MyDrHank

Site position #106 · C

Strengths

  • Public landing and product pages show starting prices before medical intake
  • Compounded injection options and a separate oral semaglutide menu are advertised, with formulation differences to discuss with the prescriber
  • Product pages advertise consultation, delivery, check-ins and unlimited clinical messaging; response times were not tested
  • Terms identify the platform operator and offer the current pharmacy-partner list on request

What to consider

  • The GLP-1 lander shows $171/$200 injectable starting rates, while separate injection pages show $178/$240; applicable purchase terms remain unresolved
  • Published base plan fields do not establish that a particular promotion is unavailable or what an individual will actually pay
  • The reviewed GLP-1 terms did not establish the cancellation cutoff, unused-prepayment refund formula or declined-treatment financial outcome
  • The assigned medical practice, prescriber and dispensing location remain unestablished; no current individual license verification is claimed
  • Dose, concentration, usable supply, laboratory costs and state-specific availability require confirmation
  • Compounded preparations are not FDA-approved; displayed branded-product trial results do not establish outcomes for these formulations
Tyde Wellness

Site position #40 · C+

Strengths

  • All 50 states served (full list published)
  • Transparent pricing: semaglutide from $149/mo, tirzepatide from $249/mo
  • LegitScript Certified with a verification link
  • Five named 503A pharmacy partners with addresses: Belmar (CO), Casa (TX), Olympia (FL), Red Rock (UT), Beaker (TX)
  • Free consultation; cancel-anytime subscription with no long-term commitment

What to consider

  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
  • No brand-name GLP-1s (Wegovy, Zepbound, Mounjaro, Ozempic)
  • Tirzepatide priced higher than competitors offering $200-$249/mo
  • Corporate address and medical director not publicly disclosed
  • No NABP.pharmacy seal visible

Featured provider

MyDrHank

MyDrHank scores 68.2/100 (C). MyDrHank advertises compounded tablets and injections, but its GLP-1 landing page and separate product pages show different starting prices; get one written offer before choosing a term.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard